Page 21 - Aallergic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Background: Currently there is no systematic review and meta-analysis of the global incidence rates of anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines in the general adult population. Objectives: To estimate the incidence rates of anaphylactic and nonanaphylactic reactions after COVID-19 vaccines and describe the demographic and clinical characteristics, triggers, presenting signs and symptoms, treatment and clinical course of confirmed cases. Design: A systematic review and meta-analysis. Preferred Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA] statement w...

There's something wrong with your dog. Her face is three times bigger than normal.

Hamad Medical Corporation (HMC) has introduced new advanced treatment for several allergic disorders as it aspires to provide first-class service to the population of Qatar in line with international standards.

The EV, plug in and hybrid revolution is slowly but steadily ensuring a marginal to decent share of the market to alternate, non ICE vehicles in almost every civilised country in the world. Maruti

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced the launch of CORAP (Community for Research in Allergic Patients). The CORAP programme notably